Share Value Dilution from the Exercise of Subscription Rights to Shares
First written in FY2016. 3 of 8 entries say "Mitigated", first in FY2018. Latest entry: FY2021.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
50 other companies' latest entry also says "Mitigated".
- FY2021MitigatedAnnual report
「As of the end of August 2021, the number of potential shares arising from these share acquisition rights and other instruments was 712,400 shares, equivalent to 0.83% of the total number of issued shares of 85,486,500.」
The percentage of potential shares fell from 0.84% in the previous quarter to 0.83%. - FY2021-Q3RestatedAnnual report
「As of the end of May 2021, the number of potential shares arising from these share acquisition rights and other instruments was 718,800 shares, equivalent to 0.84% of the total number of issued shares of 85,486,500.」
The risk of dilution from the exercise of share acquisition rights continues to be identified, with the percentage of potential shares unchanged at 0.84% from the previous quarter's disclosure. - FY2021-Q2WorsenedAnnual report
「As of the end of February 2021, the number of potential shares arising from these share acquisition rights and other instruments was 718,800 shares, equivalent to 0.84% of the total number of issued shares of 85,486,500.」
The percentage of potential shares increased from the previously stated 0.04% to 0.84%. The issuance of the 12th and 13th Series of Share Acquisition Rights increased dilution exposure. - FY2020MitigatedAnnual report
「As of the end of August 2020, the number of potential shares arising from these share acquisition rights and other instruments was 31,200 shares, equivalent to 0.04% of the total number of issued shares of 85,486,500.」
The percentage of potential shares fell from the previous 5.4% to 0.04%, reducing dilution exposure. The 11th Series of Share Acquisition Rights was also acquired and cancelled. - FY2019WorsenedAnnual report
「As of the end of August 2019, the number of potential shares arising from these share acquisition rights and other instruments was 2,415,100 shares, equivalent to 5.4% of the total number of issued shares of 44,390,500.」
The percentage of potential shares increased from the previously stated 4.96% to 5.4%, increasing dilution exposure. - FY2019-Q3WorsenedAnnual report
「2,200,000 shares (4.96% of total issued shares)」
For the 11th Series of Share Acquisition Rights, an additional maximum of 2,200,000 potential shares, equivalent to 4.96% of total issued shares, was disclosed, increasing dilution exposure. - FY2018MitigatedAnnual report
「As of the end of August 2018, the number of potential shares arising from these share acquisition rights and other instruments was 845,600 shares, equivalent to 1.9% of the total number of issued shares of 44,390,400.」
The percentage of potential shares relative to total issued shares fell to 1.9% from the previously stated 4.6%. The figures reflect the post-stock-split number of shares, and the exercise of stock options is also reported. - FY2016First statedAnnual report
「As of the end of August 2016, the number of potential shares arising from these share acquisition rights and other instruments was 510,000 shares, equivalent to 4.6% of the total number of issued shares of 11,097,600.」
The risk of dilution of equity value upon exercise of rights is identified for 510,000 potential shares, representing 4.6% of total issued shares.